A Risk-Stratified Approach to Prostate-Specific Antigen Screening
Author:
Publisher
Elsevier BV
Subject
Urology
Reference10 articles.
1. Mortality results from a randomized prostate-cancer screening trial;Andriole;N Engl J Med,2009
2. Screening and prostate-cancer mortality in a randomized European study;Schröder;N Engl J Med,2009
3. Prostate cancer mortality reduction by prostate-specific antigen–based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC);Roobol;Eur Urol,2009
4. Crawford ED, Grubb R III, Black A, et al. Comorbidity and mortality results from a randomized prostate cancer screening trial. J Clin Oncol. In press.
5. Contemporary trends in low risk prostate cancer: risk assessment and treatment;Cooperberg;J Urol,2007
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Expression patterns and bioinformatic analysis of miR-1260a and miR-1274a in Prostate Cancer Tunisian patients;Molecular Biology Reports;2018-09-24
2. The role of miRNAs in the development of prostate cancer;Russian Journal of Genetics;2015-07
3. Prostate-specific antigen screening, why have the guidelines changed?;Expert Review of Anticancer Therapy;2014-10-13
4. MicroRNA as New Tools for Prostate Cancer Risk Assessment and Therapeutic Intervention: Results from Clinical Data Set and Patients’ Samples;BioMed Research International;2014
5. REVIEW ARTICLES PSA mass screening: is there enough evidence?;Central European Journal of Urology;2012
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3